It is a healthcare private limited company based in Nagpur, Maharashtra, India, established in 2013.
2013 | Nagpur, Maharashtra, India | ActiveElitra Pharmaceuticals Private Limited, a active private limited company, was established on 06 November 2013 in Nagpur, Maharashtra, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U85190MH2013PTC249852. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kanchan Ashish Ambare (Director), Sachin Ingole Bhimraoji (Director), Pinki Bhaskar Paunikar (Director). Past directors included Roshan Dadave Chandradas, Bhaskar Manoharao Paunikar, Kishor Raghatate. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Qr 1/3, Raghogi Nagar, Nagpur, Maharashtra, 440009.
U85190MH2013PTC249852
249852
06 November 2013
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Elitra Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kanchan Ashish Ambare | Director | 04 Feb 2016 | Current |
| Sachin Ingole Bhimraoji | Director | 04 Feb 2016 | Current |
| Pinki Bhaskar Paunikar | Director | 22 Dec 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 10 Feb 2016 | Past |
| Pramod Abcsdd | Director | 05 Jan 2015 | Past |
| Pramod Abcsdd | Director | 11 Jun 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 10 Feb 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elitra Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Elitra Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Elitra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Elitra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elitra Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Elitra Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Elitra Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Kanchan Ashish Ambare was appointed as a Director was appointed as a Director on 04 Feb 2016 & has been associated with this company since 9 years 10 months . was recorded as a recent event.
The activity Sachin Ingole Bhimraoji was appointed as a Director was appointed as a Director on 04 Feb 2016 & has been associated with this company since 9 years 10 months . was completed.
Pinki Bhaskar Paunikar was appointed as a Director was appointed as a Director on 22 Dec 2014 & has been associated with this company since 10 years 11 months . was recorded as a recent event.
Progress on Elitra Pharmaceuticals Private Limited was registered on 06 Nov 2013 with Roc Mumbai & aged 12 years 1 month as per MCA records. was documented.
The CIN of Elitra Pharmaceuticals Private Limited is U85190MH2013PTC249852.
Elitra Pharmaceuticals Private Limited is headquartered at Qr 1/3, Raghogi Nagar, Nagpur, Maharashtra, 440009.
Elitra Pharmaceuticals Private Limited was incorporated on 06 November 2013.
The current directors of Elitra Pharmaceuticals Private Limited are
The primary industry of Elitra Pharmaceuticals Private Limited is Hospital And Medical Care.
Elitra Pharmaceuticals Private Limited is unlisted.
The authorized capital of Elitra Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Elitra Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX